Correction to: MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies

Correction to: MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies

Saved in:
Bibliographic Details
Published in:Cell death & disease Vol. 15; no. 7; pp. 526 - 3
Main Authors: Choudhary, G. S., Al-harbi, S., Mazumder, S., Hill, B. T., Smith, M. R., Bodo, J., Hsi, E. D., Almasan, A.
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 24-07-2024
Springer Nature B.V
Nature Publishing Group
Subjects:
1-Phosphatidylinositol 3-kinase
AKT protein
Antibodies
Bcl-2 protein
Bcl-x protein
Biochemistry
Biomedical and Life Sciences
Cell Biology
Cell Culture
Correction
Immunology
Life Sciences
Malignancy
Mcl-1 protein
TOR protein
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:correction
ObjectType-Correction/Retraction-1
content type line 23
SourceType-Scholarly Journals-1
ISSN:2041-4889
2041-4889
DOI:10.1038/s41419-024-06878-1